The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| RCEL | -51.52% | -84.63% | -31.24% | -83% |
| S&P | +15.4% | +78.67% | +12.31% | +393% |
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $17.06M | -12.7% |
| Gross Profit | $13.88M | -15.2% |
| Gross Margin | 81.32% | -2.4% |
| Market Cap | $126.95M | -52.3% |
| Market Cap / Employee | $488.26K | 0.0% |
| Employees | 260 | 0.0% |
| Net Income | -$13,187.00K | 18.6% |
| EBITDA | -$8,579.00K | 36.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $15.42M | -17.3% |
| Accounts Receivable | $9.01M | -12.4% |
| Inventory | 7.2 | 16.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.32M | -94.9% |
| Short Term Debt | $42.45M | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -67.07% | 3.7% |
| Return On Invested Capital | -65.05% | -29.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$6,488.52K | 43.3% |
| Operating Free Cash Flow | -$5,528.07K | 27.4% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 27.45 | 47.68 | -30.59 | -10.55 | -190.69% |
| Price to Sales | 5.21 | 2.98 | 1.86 | 2.00 | -56.80% |
| Price to Tangible Book Value | 28.84 | -200.30 | -13.96 | -7.47 | -162.77% |
| Enterprise Value to EBITDA | -35.98 | -20.52 | -15.89 | -19.41 | -6.36% |
| Return on Equity | -231.0% | -407.5% | -935.7% | -1746.3% | 1045.55% |
| Total Debt | $45.99M | $44.07M | $44.59M | $44.77M | -1.87% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
